RoxP Antibodies for Rapid Cutibacterium Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying Cutibacterium infections are delayed due to the requirement of extended anaerobic cultivation, leading to timely medical intervention challenges, especially in device-related and postoperative infections.
Innovation Solution
Development of monoclonal antibodies specifically targeting the RoxP protein of Cutibacterium, which can be used for efficient detection of Cutibacterium species with minimal signal from contaminating bacteria, employing epitope binding agents that bind to RoxP and utilizing these antibodies in diagnostic and therapeutic compositions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If extended anaerobic cultivation is used to identify C. acnes infections, then diagnostic accuracy is improved, but time delay increases
Solution Approach 1:
The patent extracts the diagnostic function from the time-consuming cultivation process by developing antibodies that directly detect C. acnes-specific antigens in clinical samples, eliminating the need for extended anaerobic cultivation while maintaining diagnostic accuracy
Solution Approach 2:
The patent performs preliminary action by pre-developing highly specific monoclonal antibodies against C. acnes antigens before clinical application, enabling rapid direct detection of infections without requiring the time-consuming cultivation step that previously preceded diagnosis
2Measurement precision
If specific detection methods are developed to reduce contamination signals, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent applies local quality by engineering antibodies with highly specific binding characteristics tailored to C. acnes-specific antigens, enabling the detection system to distinguish target bacteria from contaminants through localized molecular recognition rather than complex system-level controls
Solution Approach 2:
The patent uses monoclonal antibodies as precise molecular copies that specifically recognize and bind to C. acnes antigens, creating a simplified detection system where the antibody-antigen interaction itself provides the specificity needed to eliminate contamination signals without additional complex filtering mechanisms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The antibodies enable rapid and specific detection of Cutibacterium species, facilitating timely medical intervention and treatment by quantifying RoxP levels in samples, thereby improving diagnostic accuracy and patient outcomes.
Implementation Method 1
monoclonal antibodies specifically targeting the RoxP protein of Cutibacterium, which can be used for efficient detection of Cutibacterium species
Data Source
AI summary
Disclosures herein are directed to antibodies and epitope binding agents that specifically bind to RoxP of Cutebacterium sp. and compositions thereof for use in clinical and non-clinical applications.